These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9055136

  • 41. Effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of clopidogrel in rats.
    Chen F, Yang Y, Fang C, Zhao J, Han M, Zhu Q, Bai X, Liu M, Yang G.
    Xenobiotica; 2015; 45(12):1122-8. PubMed ID: 26068527
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Aspirin decreases systemic exposure to clopidogrel through modulation of P-glycoprotein but does not alter its antithrombotic activity.
    Oh J, Shin D, Lim KS, Lee S, Jung KH, Chu K, Hong KS, Shin KH, Cho JY, Yoon SH, Ji SC, Yu KS, Lee H, Jang IJ.
    Clin Pharmacol Ther; 2014 Jun; 95(6):608-16. PubMed ID: 24566733
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The effect of ticlopidine on canine platelets, fibrinogen, and antithrombin III activity.
    Boudreaux MK, Jeffers C, Lipscomb D, Spano JS.
    J Vet Pharmacol Ther; 1992 Mar; 15(1):1-9. PubMed ID: 1573697
    [Abstract] [Full Text] [Related]

  • 47. Pharmacokinetics and pharmacodynamics of Ro 44-3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers.
    Wittke B, Mackie IJ, Machin SJ, Timm U, Zell M, Goggin T.
    Br J Clin Pharmacol; 1999 May; 47(5):521-30. PubMed ID: 10336576
    [Abstract] [Full Text] [Related]

  • 48. Clinical bioequivalence of a dose of clopidogrel Leti Cravid tablets 75 mg versus clopidogrel Sanofi Plavix tablets 75 mg administered on a daily dose for 7 days on healthy volunteers: a clinical trial.
    Müller A, Octavio J, González MY, Contreras J, Méndez G, Portillo M, Valero Z.
    Am J Ther; 2010 May; 17(3):351-6. PubMed ID: 20019589
    [Abstract] [Full Text] [Related]

  • 49. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
    Goto S, Tamura N, Sakakibara M, Ikeda Y, Handa S.
    Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
    [Abstract] [Full Text] [Related]

  • 50. Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease.
    Lev EI, Arikan ME, Vaduganathan M, Alviar CL, Tellez A, Mathuria N, Builes A, Granada JF, del Conde I, Kleiman NS.
    Am Heart J; 2007 Oct; 154(4):694.e1-7. PubMed ID: 17892993
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Clopidogrel and drug metabolism: absence of effect on hepatic enzymes in healthy volunteers.
    Pierce CH, Houle JM, Dickinson JP, Kindermans M, Serre-Lacroix E, Kieffer G, Necciari J.
    Semin Thromb Hemost; 1999 Oct; 25 Suppl 2():35-9. PubMed ID: 10440421
    [Abstract] [Full Text] [Related]

  • 55. Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions.
    Kleiman NS, Grazeiadei N, Maresh K, Taylor RJ, Frederick B, Lance ET, Effron MB, Jordan RE, Mascelli MA.
    Am Heart J; 2000 Sep; 140(3):492-501. PubMed ID: 10966553
    [Abstract] [Full Text] [Related]

  • 56. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention.
    Hochholzer W, Trenk D, Frundi D, Blanke P, Fischer B, Andris K, Bestehorn HP, Büttner HJ, Neumann FJ.
    Circulation; 2005 May 24; 111(20):2560-4. PubMed ID: 15809367
    [Abstract] [Full Text] [Related]

  • 57. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.
    Gachet C, Cazenave JP, Ohlmann P, Bouloux C, Defreyn G, Driot F, Maffrand JP.
    Biochem Pharmacol; 1990 Dec 15; 40(12):2683-7. PubMed ID: 2175608
    [Abstract] [Full Text] [Related]

  • 58. Effect of plasma fibrinogen concentration on the inhibition of platelet aggregation after ticlopidine compared with aspirin.
    Tohgi H, Takahashi H, Kashiwaya M, Watanabe K.
    Stroke; 1994 Oct 15; 25(10):2017-21. PubMed ID: 8091447
    [Abstract] [Full Text] [Related]

  • 59. Genetic polymorphisms and the impact of a higher clopidogrel dose regimen on active metabolite exposure and antiplatelet response in healthy subjects.
    Simon T, Bhatt DL, Bergougnan L, Farenc C, Pearson K, Perrin L, Vicaut E, Lacreta F, Hurbin F, Dubar M.
    Clin Pharmacol Ther; 2011 Aug 15; 90(2):287-95. PubMed ID: 21716274
    [Abstract] [Full Text] [Related]

  • 60. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH, Schmidt EB, Maurer-Spurej E, Kristensen SR.
    Platelets; 2008 Aug 15; 19(5):335-41. PubMed ID: 18791939
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.